{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "12",
          "submission_status": "AP",
          "submission_status_date": "20210415",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "67090",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/050789Orig1s012ltr.pdf",
              "date": "20210419",
              "type": "Letter"
            },
            {
              "id": "67097",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050789s012lbl.pdf",
              "date": "20210419",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "8",
          "submission_status": "AP",
          "submission_status_date": "20130216",
          "review_priority": "STANDARD",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "6",
          "submission_status": "AP",
          "submission_status_date": "20200403",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "62454",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/050789Orig1s006lbl.pdf",
              "date": "20200406",
              "type": "Label"
            },
            {
              "id": "62461",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/050789Orig1s006ltr.pdf",
              "date": "20200407",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "27",
          "submission_status": "AP",
          "submission_status_date": "20090810",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "8293",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/050789s027ltr.pdf",
              "date": "20091127",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "17",
          "submission_status": "AP",
          "submission_status_date": "20230210",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "73462",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/050789Orig1s017ltr.pdf",
              "date": "20230213",
              "type": "Letter"
            },
            {
              "id": "73471",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/050789s017lbl.pdf",
              "date": "20230213",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5",
          "submission_status": "AP",
          "submission_status_date": "20090810",
          "submission_public_notes": "Please see <a href=\"https://www.fda.gov/STIC/\">www.fda.gov/STIC</a> for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs.",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "39337",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/050789s005lbl.pdf",
              "date": "20090922",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20040713",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 5",
          "submission_class_code_description": "Type 5 - New Formulation or New Manufacturer",
          "application_docs": [
            {
              "id": "39336",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/50789lbl.pdf",
              "date": "20040721",
              "type": "Label"
            },
            {
              "id": "42739",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/050789s000_TobramycinTOC.html",
              "date": "20061025",
              "type": "Review"
            },
            {
              "id": "30547",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/50789ltr.pdf",
              "date": "20040721",
              "type": "Letter"
            }
          ]
        }
      ],
      "application_number": "NDA050789",
      "sponsor_name": "FRESENIUS KABI USA",
      "openfda": {
        "application_number": [
          "NDA050789"
        ],
        "brand_name": [
          "TOBRAMYCIN"
        ],
        "generic_name": [
          "TOBRAMYCIN SULFATE"
        ],
        "manufacturer_name": [
          "Fresenius Kabi USA, LLC"
        ],
        "product_ndc": [
          "63323-303"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS"
        ],
        "substance_name": [
          "TOBRAMYCIN SULFATE"
        ],
        "rxcui": [
          "597823"
        ],
        "spl_id": [
          "ea244093-d87f-4192-b5c4-59d7b7dbf669",
          "473ebf35-f2d4-46fb-9463-3fe402309c01"
        ],
        "spl_set_id": [
          "d62ff359-912b-4be1-9fc2-2dde8777eefb",
          "9a5cecd6-aa65-42d2-b15a-06b4fcebcc0f"
        ],
        "package_ndc": [
          "63323-303-01",
          "63323-303-51",
          "63323-303-21",
          "63323-303-55"
        ],
        "unii": [
          "HJT0RXD7JK"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "TOBRAMYCIN SULFATE",
          "active_ingredients": [
            {
              "name": "TOBRAMYCIN SULFATE",
              "strength": "EQ 1.2GM BASE/VIAL"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "INJECTABLE",
          "route": "INJECTION",
          "marketing_status": "Prescription",
          "te_code": "AP"
        }
      ]
    }
  ]
}